OMCL
Omnicell, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$34.37
−1.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.2B | 1.2B | 1.1B | 1.1B | 1.3B |
| Cost of Revenue | 688.6M | 676.8M | 641.2M | 647.2M | 707.0M |
| Gross Profit | 558.1M | 508.0M | 471.0M | 499.9M | 589.0M |
| Operating Expenses | |||||
| R&D Expense | 88.4M | 87.7M | 90.4M | 93.3M | 105.0M |
| SG&A Expense | 410.8M | 408.6M | 380.3M | 426.0M | 486.3M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 499.2M | 496.4M | 470.7M | 519.3M | 591.3M |
| Cost and Expenses | 1.2B | 1.2B | 1.1B | 1.2B | 1.3B |
| Operating Income (EBIT) | 59.0M | 11.7M | 337.0K | (19.3M) | (2.3M) |
| Non-Operating | |||||
| Interest Income | 6.1M | 11.9M | 24.9M | 14.8M | — |
| Interest Expense | 3.9M | 3.9M | 4.5M | — | 130.0K |
| Net Interest Income | 2.2M | 8.0M | 20.4M | 14.8M | (130.0K) |
| Other Non-Op Income/Expense | 2.2M | (340.0K) | 25.3M | (779.0K) | (130.0K) |
| Non-Operating Income (excl Interest) | (4.0M) | (3.6M) | (29.8M) | (3.8M) | — |
| EBT (Pre-Tax Income) | 61.1M | 11.3M | 25.6M | (20.1M) | (2.5M) |
| Income Tax Expense | 22.1M | 9.3M | 13.1M | 263.0K | (8.1M) |
| Bottom Line | |||||
| Net Income | 39.1M | 2.1M | 12.5M | (20.4M) | 5.6M |
| Earnings from Cont. Ops | 39.1M | 2.1M | 12.5M | (20.4M) | 5.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 39.1M | 2.1M | 12.5M | (20.4M) | 5.6M |
| Per Share | |||||
| Basic EPS | $0.85 | $0.04 | $0.27 | ($0.45) | $0.13 |
| Diluted EPS | $0.84 | $0.04 | $0.27 | ($0.45) | $0.12 |
| Revenue Per Share | $27.42 | $25.78 | $24.15 | $25.37 | $29.19 |
| Shares | |||||
| Basic Shares Outstanding | 45.5M | 46.0M | 46.0M | 45.2M | 44.4M |
| Diluted Shares Outstanding | 46.1M | 46.4M | 46.3M | 45.2M | 45.9M |
| Profitability Metrics | |||||
| EBITDA | 106.1M | 101.9M | 119.9M | 80.0M | 96.8M |
| D&A | 43.1M | 86.6M | 89.8M | 95.6M | 99.2M |
| EBIT | 62.9M | 15.2M | 30.1M | (15.6M) | (2.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026